Friedler, S., Meltzer, S., Saar-Ryss, B., Rabinson, J., Lazer, T., & Liberty, G. (2016). An upper limit of gonadotropin dose in patients undergoing ART should be advocated. Gynecological Endocrinology, 32(12), 965. https://doi.org/10.1080/09513590.2016.1199018
Chicago Style (17th ed.) CitationFriedler, S., S. Meltzer, B. Saar-Ryss, J. Rabinson, T. Lazer, and G. Liberty. "An Upper Limit of Gonadotropin Dose in Patients Undergoing ART Should Be Advocated." Gynecological Endocrinology 32, no. 12 (2016): 965. https://doi.org/10.1080/09513590.2016.1199018.
MLA (9th ed.) CitationFriedler, S., et al. "An Upper Limit of Gonadotropin Dose in Patients Undergoing ART Should Be Advocated." Gynecological Endocrinology, vol. 32, no. 12, 2016, p. 965, https://doi.org/10.1080/09513590.2016.1199018.